CD8+ T cells are cytotoxic T cells that are considered major drivers of antitumor immunity, while CD4+ T cells, including Th1, Th2, Th17, and Treg cells, play a prominent role in controlling tumor growth 79. Here, CD8A is linked to neoplasm.